Propofol is the sedation infusion of choice for intubated patients with raised ICP
For intubated patients with elevated intracranial pressure, propofol (combined with an opioid such as fentanyl) is the preferred continuous sedative infusion in normotensive or hypertensive patients. In hypotensive patients, consider midazolam with fentanyl or ketamine as alternatives 1.
Rationale and Evidence Hierarchy
The 2018 Critical Care Medicine guidelines establish that nonbenzodiazepine sedatives (propofol or dexmedetomidine) are preferable to benzodiazepines for mechanically ventilated critically ill adults 2. However, when specifically addressing raised ICP, the evidence becomes more nuanced:
Propofol: First-Line Choice
- Reduces cerebral metabolic rate and ICP effectively while maintaining adequate sedation 3, 4
- Propofol and midazolam show equivalent efficacy and safety profiles, but propofol offers shorter wake-up times which is crucial for neurological assessments 5
- The 2023 scoping review confirms propofol's efficacy without notable safety concerns at standard doses 3
Critical Caveat: Blood Pressure Matters
High-dose propofol may disrupt cerebral autoregulation and cause hypotension 3. This is the key decision point:
- Normotensive/Hypertensive patients: Propofol + fentanyl 1
- Hypotensive patients: Switch to midazolam + fentanyl OR ketamine monotherapy 1
Opioid Selection
Combine your sedative with an opioid, but avoid bolus dosing of opioids as de novo boluses increase ICP and reduce cerebral perfusion pressure 3. Use continuous infusions of:
- Remifentanil, sufentanil, or fentanyl (all proven safe for continuous application) 5
- High-dose fentanyl can blunt sympathetic stimulation during intubation 1
Alternative Agents
Ketamine has emerged as a viable option, contradicting older dogma:
- Ketamine boluses and infusions are not associated with increased ICP 3
- May reduce cortical spreading depolarization events 3
- Safe when combined with mechanical ventilation and GABA receptor agonists 5
- Particularly useful in hypotensive patients 1
Dexmedetomidine considerations:
- Effective for achieving target sedation scores 3
- Major limitation: causes clinically significant hypotension, especially when combined with propofol 3
- Less suitable for raised ICP management given hemodynamic instability risks
Benzodiazepines (midazolam):
- Equally safe and effective as propofol 5
- Longer wake-up times compromise neurological monitoring 5
- Reserve for hypotensive patients where propofol is contraindicated
Common Pitfalls
- Using opioid boluses: This consistently increases ICP—use continuous infusions only 3
- High-dose propofol in all patients: Monitor for hypotension and autoregulation disruption 3
- Avoiding ketamine reflexively: Historical concerns about ICP elevation are not supported by current evidence 3, 5
- Deep sedation by default: Target light sedation (RASS -1 to +1) unless intracranial hypertension specifically requires deeper sedation (RASS -5) 5
Monitoring Framework
The 2014 consensus statement emphasizes that ICP treatment is best guided by ICP monitoring, clinical imaging, and clinical evaluation used in combination within a structured protocol 6. Continuous sedation should be titrated to: